These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 19504818)

  • 21. Drugs for cognitive loss and dementia.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):155-161. PubMed ID: 28922342
    [No Abstract]   [Full Text] [Related]  

  • 22. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Feldman H; Anand R; Blesa R; Dubois B; Gray J; Homma A; Mohr E; Morris JC; Parys W; Raschig A; Robillard A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():61-4. PubMed ID: 9305520
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dementia--treatment].
    Stoppe G; Stiens G; Staedt J
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1544-6; quiz 147-50. PubMed ID: 12854065
    [No Abstract]   [Full Text] [Related]  

  • 24. [Competence groups of patients with dementia: directing attention to resources].
    Kruse A; Schmitt E
    Pflege Z; 2008 Feb; 61(2):77-81. PubMed ID: 18386684
    [No Abstract]   [Full Text] [Related]  

  • 25. Cognitive, affective, and psychiatric features of Parkinson's disease.
    Barbas NR
    Clin Geriatr Med; 2006 Nov; 22(4):773-96, v-vi. PubMed ID: 17000335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE
    J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life].
    Lökk J; Winblad B
    Lakartidningen; 2006 Feb 15-21; 103(7):451-5. PubMed ID: 16535872
    [No Abstract]   [Full Text] [Related]  

  • 28. Donepezil in the treatment of patients with Alzheimer's disease.
    Tsuno N
    Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of psycho-behavioral disorders in the elderly].
    Gallarda T
    Encephale; 2011 Sep; 37(4 Suppl 4):H26-8. PubMed ID: 22108186
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacoeconomics of dementia.
    Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 5():S22-32; discussion S32-3. PubMed ID: 9348424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Levy R
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anti-Alzheimer drugs: ethical aspects of research and practice].
    Berghmans RL
    Tijdschr Gerontol Geriatr; 2000 Jun; 31(3):100-6. PubMed ID: 10900662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric outcome for clinical trials.
    Robert P; Verhey FR; Aalten P; Cortes F; Byrne EJ
    J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496
    [No Abstract]   [Full Text] [Related]  

  • 34. Recognizing apathy in Alzheimer's disease.
    Lerner AJ; Strauss M; Sami SA
    Geriatrics; 2007 Nov; 62(11):14-7. PubMed ID: 17999565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison table: drugs for Alzheimer's disease.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):e160-e161. PubMed ID: 28922344
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychopharmacology and Alzheimer's disease.
    Serby M
    J Adv Med Surg Nurs; 1989 Mar; 1(2):32-9. PubMed ID: 2664071
    [No Abstract]   [Full Text] [Related]  

  • 37. [Also consider non-cognitive disorders].
    Krankenpfl J; 2005; 43(7-10):211-2. PubMed ID: 16515283
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical trials of treatment for noncognitive symptoms of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Homma A; Brodaty H; Bruno G; Cummings JL; Gilman S; Gracon S; McKeith IG
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():54-5. PubMed ID: 9305518
    [No Abstract]   [Full Text] [Related]  

  • 39. [When should the medication for dementia be stopped?].
    Pitkälä K
    Duodecim; 2003; 119(9):817-8. PubMed ID: 12815978
    [No Abstract]   [Full Text] [Related]  

  • 40. Information technology and the International Working Group on Harmonization of Dementia Drug Guidelines.
    Harvey RJ; Sciulli CG; Mason RM; Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():29-32. PubMed ID: 9305512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.